Urology News

Prostate Cancer

Predictors of PSA Persistence After RP for Node-Positive Prostate Cancer ID’d

Publish Date September 25, 2023

Study supports the role of PSMA PET for risk stratifying patients with clinically node-positive disease before radical prostatectomy, along with mpMRI and clinical parameters.

Urology

Searching for Surrogates: The Effort to Speed Up Drug Trials

Publish Date September 22, 2023

Surrogate endpoints can substantially shorten clinical trials and expedite approvals of new drugs, but they are elusive and sometimes controversial.

Benign Prostatic Hyperplasia (BPH)

Treatment of Lower Urinary Tract Symptoms Tied to Reduced Risk for Death in Men

Publish Date September 22, 2023

Significant reductions seen in death with 1-point improvement in AUA Symptom Score, and in storage and voiding subscales

Bladder Cancer

Less Aggressive Chemoradiation for MIBC Tested in Noncystectomy Patients

Publish Date September 21, 2023

A study tested a less aggressive chemoradiation protocol in patients with muscle-invasive bladder cancer (MIBC) unfit for surgery due to older age or comorbidities.

Urology

Testicular Cancer Guidelines Updated

Publish Date September 20, 2023

Surveillance plays a major role in the management of men with cancer clinically confined to the testis.

Urology

Linguistic Disparities Impact Patient Access to Cancer Care

Publish Date September 20, 2023

Non-English-speaking patient callers to hospital are less likely to be provided with next steps to access cancer care

Urology

AACR Cancer Progress Report Reveals 33% Decrease in Cancer Death Rate, 1990 to 2020

Publish Date September 19, 2023

Report highlights advances such as approval of 14 new anticancer therapeutics, expansion of use of 12 previously approved therapeutics

Overactive Bladder (OAB)

Early Clean Intermittent Catheterization Recommended With Neurogenic Bladder

Publish Date September 19, 2023

High-grade vesicoureteral reflux is crucial risk factor for recurrent febrile urinary tract infections in children

Prostate Cancer

Comparing Medicare Drug Plans May Ease Prostate Cancer Financial Toxicity

Publish Date September 18, 2023

Less than 30% of patients report comparing drug costs before selecting a Medicare Part D plan.

Bladder Cancer

Adding Ipilimumab to Nivolumab Doesn’t Provide Meaningful Benefit, Researchers Say

Publish Date September 18, 2023

Adding ipilimumab to treatment with nivolumab does not provide a clinically meaningful benefit in patients with certain cancers, a meta-analysis suggests.